JAG CAPITAL MANAGEMENT, LLC

Position in ABBV — AbbVie Inc.

CIK 1080374 ST LOUIS, MO

Position in ABBV

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$228,237

+$20,540 QoQ

Shares Held

907

-0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#3,859

of 4,153 holders

Holding Since

Jun 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JAG CAPITAL MANAGEMENT, LLC holds $31,314,287 across 6 Drug Manufacturers - General names. ABBV ranks #6 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	22,275	$26,717,305
2	GILD	Gilead Sciences, Inc.	26,123	$3,300,379
3	AMGN	Amgen Inc	1,144	$414,265
4	JNJ	Johnson & Johnson	1,472	$373,843
5	MRK	Merck & Co., Inc.	2,181	$280,258
6	ABBV	AbbVie Inc. This page	907	$228,237

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$228,237	907	-0.2%	Shares	Sole	2026-07-29
2025-12-31	$207,697	909	+0.3%	Shares	Sole	2026-02-06
2025-09-30	$209,775	906	-27.9%	Shares	Sole	2025-11-10
2025-06-30	$233,138	1,256	+21.0%	Shares	Sole	2025-07-28
2025-03-31	$217,481	1,038	-64.7%	Shares	Sole	2025-04-24
2024-12-31	$522,793	2,942	+145.6%	Shares	Sole	2025-02-06
2024-09-30	$236,581	1,198	+2.7%	Shares	Sole	2024-11-04
2024-06-30	$200,163	1,167	0.0%	Shares	Sole	2024-07-30
2024-03-31	$212,510	1,167	-90.2%	Shares	Sole	2024-05-01
2023-09-30	$1,768,000	11,861	+1.3%	Shares	Sole	2023-11-15
2023-06-30	$1,577,823	11,711	-3.5%	Shares	Sole	2023-09-07
2023-03-31	$1,934,592	12,139	-0.8%	Shares	Sole	2023-09-07
2022-12-31	$1,978,429	12,242	-6.5%	Shares	Sole	2023-09-07
2022-09-30	$1,757,211	13,093	+2.3%	Shares	Sole	2022-11-14
2022-06-30	$1,959,682	12,795	—	Shares	Sole	2022-08-01
No filing history on record for this holder in this stock.